nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ALB—pancreatitis	0.45	1	CbGaD
Gefitinib—ORM1—bile—pancreatitis	0.0161	0.122	CbGeAlD
Gefitinib—ERBB3—exocrine gland—pancreatitis	0.00949	0.0716	CbGeAlD
Gefitinib—Blepharitis—Hyoscyamine—pancreatitis	0.00578	0.0754	CcSEcCtD
Gefitinib—SBK1—blood—pancreatitis	0.00561	0.0424	CbGeAlD
Gefitinib—Electrocardiogram QT prolonged—Hyoscyamine—pancreatitis	0.00553	0.0722	CcSEcCtD
Gefitinib—Keratitis—Hyoscyamine—pancreatitis	0.00548	0.0715	CcSEcCtD
Gefitinib—CSNK1E—islet of Langerhans—pancreatitis	0.00542	0.0409	CbGeAlD
Gefitinib—IRAK4—islet of Langerhans—pancreatitis	0.00533	0.0403	CbGeAlD
Gefitinib—MKNK2—islet of Langerhans—pancreatitis	0.00497	0.0376	CbGeAlD
Gefitinib—IRAK1—islet of Langerhans—pancreatitis	0.00497	0.0376	CbGeAlD
Gefitinib—CHEK2—blood—pancreatitis	0.00489	0.0369	CbGeAlD
Gefitinib—ORM1—gall bladder—pancreatitis	0.00447	0.0338	CbGeAlD
Gefitinib—ALB—gall bladder—pancreatitis	0.00392	0.0296	CbGeAlD
Gefitinib—CSNK1E—pancreas—pancreatitis	0.00381	0.0288	CbGeAlD
Gefitinib—ERBB3—pancreas—pancreatitis	0.00368	0.0278	CbGeAlD
Gefitinib—Respiratory failure—Hyoscyamine—pancreatitis	0.00362	0.0472	CcSEcCtD
Gefitinib—MKNK2—pancreas—pancreatitis	0.0035	0.0264	CbGeAlD
Gefitinib—IRAK1—pancreas—pancreatitis	0.0035	0.0264	CbGeAlD
Gefitinib—Dry eye—Hyoscyamine—pancreatitis	0.00328	0.0428	CcSEcCtD
Gefitinib—CSNK1E—digestive system—pancreatitis	0.00325	0.0246	CbGeAlD
Gefitinib—ERBB3—digestive system—pancreatitis	0.00314	0.0237	CbGeAlD
Gefitinib—CSNK1E—blood—pancreatitis	0.0031	0.0234	CbGeAlD
Gefitinib—IRAK4—blood—pancreatitis	0.00305	0.023	CbGeAlD
Gefitinib—MKNK2—digestive system—pancreatitis	0.00299	0.0225	CbGeAlD
Gefitinib—MKNK1—digestive system—pancreatitis	0.00295	0.0223	CbGeAlD
Gefitinib—Eye pain—Hyoscyamine—pancreatitis	0.00286	0.0373	CcSEcCtD
Gefitinib—MKNK2—blood—pancreatitis	0.00284	0.0215	CbGeAlD
Gefitinib—IRAK1—blood—pancreatitis	0.00284	0.0215	CbGeAlD
Gefitinib—MKNK1—blood—pancreatitis	0.00281	0.0212	CbGeAlD
Gefitinib—Atrial fibrillation—Hyoscyamine—pancreatitis	0.00272	0.0355	CcSEcCtD
Gefitinib—Dry mouth—Propantheline—pancreatitis	0.00253	0.033	CcSEcCtD
Gefitinib—STK10—digestive system—pancreatitis	0.00243	0.0183	CbGeAlD
Gefitinib—Dehydration—Hyoscyamine—pancreatitis	0.0024	0.0313	CcSEcCtD
Gefitinib—Dry skin—Hyoscyamine—pancreatitis	0.00236	0.0309	CcSEcCtD
Gefitinib—Hypokalaemia—Hyoscyamine—pancreatitis	0.00235	0.0306	CcSEcCtD
Gefitinib—STK10—blood—pancreatitis	0.00231	0.0175	CbGeAlD
Gefitinib—Constipation—Propantheline—pancreatitis	0.00212	0.0276	CcSEcCtD
Gefitinib—MAP2K5—blood—pancreatitis	0.00206	0.0156	CbGeAlD
Gefitinib—Urticaria—Propantheline—pancreatitis	0.00197	0.0257	CcSEcCtD
Gefitinib—Conjunctivitis—Hyoscyamine—pancreatitis	0.00193	0.0252	CcSEcCtD
Gefitinib—Hypersensitivity—Propantheline—pancreatitis	0.00182	0.0238	CcSEcCtD
Gefitinib—Minaprine—HTR2A—pancreatitis	0.00179	0.288	CrCbGaD
Gefitinib—Asthenia—Propantheline—pancreatitis	0.00178	0.0232	CcSEcCtD
Gefitinib—ORM1—blood—pancreatitis	0.00168	0.0127	CbGeAlD
Gefitinib—CYP3A5—islet of Langerhans—pancreatitis	0.00163	0.0123	CbGeAlD
Gefitinib—Arrhythmia—Hyoscyamine—pancreatitis	0.00159	0.0208	CcSEcCtD
Gefitinib—Vomiting—Propantheline—pancreatitis	0.00157	0.0205	CcSEcCtD
Gefitinib—Rash—Propantheline—pancreatitis	0.00156	0.0204	CcSEcCtD
Gefitinib—Dermatitis—Propantheline—pancreatitis	0.00156	0.0204	CcSEcCtD
Gefitinib—Nausea—Propantheline—pancreatitis	0.00147	0.0192	CcSEcCtD
Gefitinib—Angioedema—Hyoscyamine—pancreatitis	0.00142	0.0185	CcSEcCtD
Gefitinib—Cisapride—HTR2A—pancreatitis	0.00142	0.228	CrCbGaD
Gefitinib—Iloperidone—HTR2A—pancreatitis	0.00131	0.21	CrCbGaD
Gefitinib—Dry mouth—Hyoscyamine—pancreatitis	0.00129	0.0169	CcSEcCtD
Gefitinib—Shock—Hyoscyamine—pancreatitis	0.00125	0.0163	CcSEcCtD
Gefitinib—CYP2C19—digestive system—pancreatitis	0.00124	0.00938	CbGeAlD
Gefitinib—Hypotension—Hyoscyamine—pancreatitis	0.00118	0.0155	CcSEcCtD
Gefitinib—CYP2C19—blood—pancreatitis	0.00118	0.00894	CbGeAlD
Gefitinib—CYP3A5—pancreas—pancreatitis	0.00115	0.00866	CbGeAlD
Gefitinib—Dyspnoea—Hyoscyamine—pancreatitis	0.00113	0.0147	CcSEcCtD
Gefitinib—Fatigue—Hyoscyamine—pancreatitis	0.00109	0.0143	CcSEcCtD
Gefitinib—Pain—Hyoscyamine—pancreatitis	0.00108	0.0141	CcSEcCtD
Gefitinib—Constipation—Hyoscyamine—pancreatitis	0.00108	0.0141	CcSEcCtD
Gefitinib—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00104	0.0135	CcSEcCtD
Gefitinib—Erlotinib—ALB—pancreatitis	0.00103	0.165	CrCbGaD
Gefitinib—Urticaria—Hyoscyamine—pancreatitis	0.00101	0.0131	CcSEcCtD
Gefitinib—ABCG2—blood—pancreatitis	0.001	0.00759	CbGeAlD
Gefitinib—Abdominal pain—Hyoscyamine—pancreatitis	0.001	0.0131	CcSEcCtD
Gefitinib—Body temperature increased—Hyoscyamine—pancreatitis	0.001	0.0131	CcSEcCtD
Gefitinib—CYP1A1—digestive system—pancreatitis	0.001	0.00756	CbGeAlD
Gefitinib—CYP3A5—digestive system—pancreatitis	0.000979	0.00739	CbGeAlD
Gefitinib—CYP2C9—digestive system—pancreatitis	0.000963	0.00728	CbGeAlD
Gefitinib—CYP1A1—blood—pancreatitis	0.000954	0.0072	CbGeAlD
Gefitinib—Hypersensitivity—Hyoscyamine—pancreatitis	0.000934	0.0122	CcSEcCtD
Gefitinib—CYP3A5—blood—pancreatitis	0.000932	0.00704	CbGeAlD
Gefitinib—CYP2C9—blood—pancreatitis	0.000918	0.00693	CbGeAlD
Gefitinib—Asthenia—Hyoscyamine—pancreatitis	0.000909	0.0119	CcSEcCtD
Gefitinib—Pruritus—Hyoscyamine—pancreatitis	0.000897	0.0117	CcSEcCtD
Gefitinib—Diarrhoea—Hyoscyamine—pancreatitis	0.000867	0.0113	CcSEcCtD
Gefitinib—ABCB1—islet of Langerhans—pancreatitis	0.000866	0.00654	CbGeAlD
Gefitinib—Vomiting—Hyoscyamine—pancreatitis	0.000806	0.0105	CcSEcCtD
Gefitinib—Rash—Hyoscyamine—pancreatitis	0.000799	0.0104	CcSEcCtD
Gefitinib—Dermatitis—Hyoscyamine—pancreatitis	0.000798	0.0104	CcSEcCtD
Gefitinib—Nausea—Hyoscyamine—pancreatitis	0.000753	0.00983	CcSEcCtD
Gefitinib—CYP3A4—digestive system—pancreatitis	0.000735	0.00555	CbGeAlD
Gefitinib—CYP2D6—digestive system—pancreatitis	0.000723	0.00546	CbGeAlD
Gefitinib—CYP3A4—blood—pancreatitis	0.0007	0.00529	CbGeAlD
Gefitinib—CYP2D6—blood—pancreatitis	0.000689	0.0052	CbGeAlD
Gefitinib—Vandetanib—ALB—pancreatitis	0.000678	0.109	CrCbGaD
Gefitinib—ABCB1—pancreas—pancreatitis	0.000609	0.0046	CbGeAlD
Gefitinib—ABCB1—digestive system—pancreatitis	0.00052	0.00393	CbGeAlD
Gefitinib—ABCB1—blood—pancreatitis	0.000495	0.00374	CbGeAlD
Gefitinib—EGFR—Signaling Pathways—PPP3CA—pancreatitis	3.12e-05	9.33e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL1B—pancreatitis	3.11e-05	9.29e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CTRB2—pancreatitis	3.09e-05	9.24e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ADH1B—pancreatitis	3.09e-05	9.24e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PTGS2—pancreatitis	3.09e-05	9.22e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—A2M—pancreatitis	3.08e-05	9.2e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—IL6—pancreatitis	3.05e-05	9.12e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—XDH—pancreatitis	3.05e-05	9.11e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—XDH—pancreatitis	3.02e-05	9.03e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ADH1B—pancreatitis	3.02e-05	9.02e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PLA2G1B—pancreatitis	3.01e-05	9e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SST—pancreatitis	3e-05	8.95e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—LPL—pancreatitis	2.99e-05	8.94e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GCG—pancreatitis	2.98e-05	8.9e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DUSP6—pancreatitis	2.97e-05	8.87e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—SPP1—pancreatitis	2.97e-05	8.86e-05	CbGpPWpGaD
Gefitinib—MKNK1—Disease—HRAS—pancreatitis	2.97e-05	8.86e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MDM2—pancreatitis	2.94e-05	8.79e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—TGFB1—pancreatitis	2.93e-05	8.75e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—A2M—pancreatitis	2.91e-05	8.69e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—LPL—pancreatitis	2.91e-05	8.69e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—MDM2—pancreatitis	2.89e-05	8.62e-05	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—HRAS—pancreatitis	2.89e-05	8.62e-05	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatitis	2.87e-05	8.57e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ADH1B—pancreatitis	2.84e-05	8.5e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NRAS—pancreatitis	2.84e-05	8.48e-05	CbGpPWpGaD
Gefitinib—MKNK1—Disease—IL6—pancreatitis	2.84e-05	8.48e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR2A—pancreatitis	2.83e-05	8.44e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	2.82e-05	8.43e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ADH1B—pancreatitis	2.82e-05	8.42e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALDH2—pancreatitis	2.82e-05	8.42e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—BDKRB2—pancreatitis	2.82e-05	8.41e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—NRAS—pancreatitis	2.82e-05	8.41e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—KRAS—pancreatitis	2.81e-05	8.39e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—INS—pancreatitis	2.8e-05	8.35e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CRP—pancreatitis	2.78e-05	8.29e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CNR1—pancreatitis	2.76e-05	8.26e-05	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—IL6—pancreatitis	2.76e-05	8.25e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CXCL8—pancreatitis	2.75e-05	8.22e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCL2—pancreatitis	2.75e-05	8.22e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PLA2G1B—pancreatitis	2.75e-05	8.21e-05	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—HRAS—pancreatitis	2.72e-05	8.12e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—KRAS—pancreatitis	2.71e-05	8.1e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—INS—pancreatitis	2.7e-05	8.05e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—FDX1—pancreatitis	2.68e-05	8.01e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—GCG—pancreatitis	2.67e-05	7.97e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALDH2—pancreatitis	2.66e-05	7.95e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TLR4—pancreatitis	2.66e-05	7.95e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-DRB1—pancreatitis	2.66e-05	7.94e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—A2M—pancreatitis	2.65e-05	7.93e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—LPL—pancreatitis	2.65e-05	7.92e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCL2—pancreatitis	2.65e-05	7.92e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TGFB1—pancreatitis	2.64e-05	7.88e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	2.64e-05	7.88e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CASP3—pancreatitis	2.63e-05	7.87e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—LEP—pancreatitis	2.63e-05	7.84e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TGFB1—pancreatitis	2.62e-05	7.81e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	2.62e-05	7.81e-05	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—IL6—pancreatitis	2.6e-05	7.78e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—NRAS—pancreatitis	2.6e-05	7.77e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	2.6e-05	7.75e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL1B—pancreatitis	2.59e-05	7.73e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—KNG1—pancreatitis	2.56e-05	7.65e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ICAM1—pancreatitis	2.55e-05	7.62e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCL2—pancreatitis	2.5e-05	7.46e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADH4—pancreatitis	2.49e-05	7.45e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—NRAS—pancreatitis	2.49e-05	7.43e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PLA2G1B—pancreatitis	2.47e-05	7.37e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—KRAS—pancreatitis	2.44e-05	7.3e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TNF—pancreatitis	2.44e-05	7.3e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ALDH2—pancreatitis	2.43e-05	7.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—KRAS—pancreatitis	2.42e-05	7.24e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PLA2G1B—pancreatitis	2.41e-05	7.19e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—NRAS—pancreatitis	2.4e-05	7.17e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—NRAS—pancreatitis	2.39e-05	7.13e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—HRAS—pancreatitis	2.39e-05	7.13e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—A2M—pancreatitis	2.38e-05	7.12e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	2.37e-05	7.07e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PDGFA—pancreatitis	2.36e-05	7.04e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PRSS1—pancreatitis	2.35e-05	7e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—LPL—pancreatitis	2.34e-05	6.99e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—pancreatitis	2.33e-05	6.97e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MDM2—pancreatitis	2.33e-05	6.95e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—A2M—pancreatitis	2.33e-05	6.94e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—HRAS—pancreatitis	2.31e-05	6.89e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL6—pancreatitis	2.28e-05	6.82e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PLA2G1B—pancreatitis	2.27e-05	6.78e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PLA2G1B—pancreatitis	2.25e-05	6.72e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—INS—pancreatitis	2.24e-05	6.7e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MDM2—pancreatitis	2.24e-05	6.7e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—KRAS—pancreatitis	2.24e-05	6.69e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TGFB1—pancreatitis	2.23e-05	6.67e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PRSS3—pancreatitis	2.22e-05	6.64e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PNLIP—pancreatitis	2.22e-05	6.64e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCL2—pancreatitis	2.21e-05	6.59e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NRAS—pancreatitis	2.21e-05	6.59e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—IL6—pancreatitis	2.21e-05	6.59e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—A2M—pancreatitis	2.19e-05	6.54e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALDH2—pancreatitis	2.18e-05	6.51e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CXCL8—pancreatitis	2.18e-05	6.5e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—A2M—pancreatitis	2.17e-05	6.49e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NRAS—pancreatitis	2.17e-05	6.47e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL5—pancreatitis	2.14e-05	6.4e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—INS—pancreatitis	2.14e-05	6.4e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—KRAS—pancreatitis	2.14e-05	6.39e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GCG—pancreatitis	2.14e-05	6.38e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALDH2—pancreatitis	2.13e-05	6.35e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	2.12e-05	6.34e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CXCL8—pancreatitis	2.1e-05	6.26e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LPL—pancreatitis	2.1e-05	6.26e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CASP3—pancreatitis	2.08e-05	6.22e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HRAS—pancreatitis	2.08e-05	6.2e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—KRAS—pancreatitis	2.07e-05	6.17e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—HRAS—pancreatitis	2.06e-05	6.15e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—KRAS—pancreatitis	2.06e-05	6.14e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TGFB1—pancreatitis	2.05e-05	6.13e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	2.04e-05	6.1e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GCG—pancreatitis	2.02e-05	6.03e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CASP3—pancreatitis	2.01e-05	5.99e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALDH2—pancreatitis	2e-05	5.99e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—XDH—pancreatitis	1.99e-05	5.96e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—pancreatitis	1.99e-05	5.94e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALDH2—pancreatitis	1.99e-05	5.93e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SPP1—pancreatitis	1.98e-05	5.93e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CXCL8—pancreatitis	1.98e-05	5.9e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—pancreatitis	1.97e-05	5.89e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.94e-05	5.79e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—MDM2—pancreatitis	1.93e-05	5.77e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.91e-05	5.7e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HRAS—pancreatitis	1.9e-05	5.68e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—KRAS—pancreatitis	1.9e-05	5.67e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2A—pancreatitis	1.89e-05	5.64e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MDM2—pancreatitis	1.87e-05	5.58e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—KRAS—pancreatitis	1.86e-05	5.57e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.86e-05	5.56e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADH1B—pancreatitis	1.86e-05	5.55e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GCG—pancreatitis	1.84e-05	5.49e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—pancreatitis	1.82e-05	5.44e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—HRAS—pancreatitis	1.82e-05	5.43e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—MDM2—pancreatitis	1.78e-05	5.32e-05	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	1.77e-05	5.29e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—HRAS—pancreatitis	1.76e-05	5.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LEP—pancreatitis	1.76e-05	5.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—HRAS—pancreatitis	1.75e-05	5.22e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CXCL8—pancreatitis	1.75e-05	5.21e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NRAS—pancreatitis	1.74e-05	5.21e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.74e-05	5.2e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—pancreatitis	1.74e-05	5.2e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1B—pancreatitis	1.73e-05	5.17e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTGS2—pancreatitis	1.72e-05	5.13e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PPARG—pancreatitis	1.71e-05	5.1e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NRAS—pancreatitis	1.68e-05	5.02e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—pancreatitis	1.68e-05	5.02e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—LPL—pancreatitis	1.68e-05	5.01e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—INS—pancreatitis	1.68e-05	5e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.67e-05	4.99e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CASP3—pancreatitis	1.67e-05	4.99e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GCG—pancreatitis	1.65e-05	4.93e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TGFB1—pancreatitis	1.62e-05	4.84e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HRAS—pancreatitis	1.61e-05	4.82e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GCG—pancreatitis	1.61e-05	4.81e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NRAS—pancreatitis	1.59e-05	4.75e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—NRAS—pancreatitis	1.59e-05	4.73e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HRAS—pancreatitis	1.58e-05	4.73e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—LPL—pancreatitis	1.58e-05	4.73e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TGFB1—pancreatitis	1.56e-05	4.67e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—pancreatitis	1.55e-05	4.62e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ALB—pancreatitis	1.54e-05	4.59e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.52e-05	4.55e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GCG—pancreatitis	1.52e-05	4.54e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—pancreatitis	1.52e-05	4.53e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GCG—pancreatitis	1.51e-05	4.5e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—KRAS—pancreatitis	1.5e-05	4.49e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—INS—pancreatitis	1.5e-05	4.48e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PLA2G1B—pancreatitis	1.48e-05	4.43e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TGFB1—pancreatitis	1.48e-05	4.42e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL2—pancreatitis	1.48e-05	4.41e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NRAS—pancreatitis	1.45e-05	4.33e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—KRAS—pancreatitis	1.45e-05	4.32e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—LPL—pancreatitis	1.44e-05	4.31e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—A2M—pancreatitis	1.43e-05	4.28e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NRAS—pancreatitis	1.4e-05	4.18e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—KRAS—pancreatitis	1.37e-05	4.09e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—KRAS—pancreatitis	1.36e-05	4.07e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—pancreatitis	1.34e-05	4.01e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—NRAS—pancreatitis	1.34e-05	3.99e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALDH2—pancreatitis	1.31e-05	3.91e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFB1—pancreatitis	1.3e-05	3.89e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—LPL—pancreatitis	1.3e-05	3.87e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HRAS—pancreatitis	1.28e-05	3.81e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—LPL—pancreatitis	1.26e-05	3.78e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MDM2—pancreatitis	1.25e-05	3.73e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—KRAS—pancreatitis	1.25e-05	3.72e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFB1—pancreatitis	1.24e-05	3.71e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HRAS—pancreatitis	1.23e-05	3.67e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARG—pancreatitis	1.22e-05	3.65e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—pancreatitis	1.22e-05	3.65e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—KRAS—pancreatitis	1.21e-05	3.6e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—INS—pancreatitis	1.2e-05	3.58e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—LPL—pancreatitis	1.19e-05	3.56e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—LPL—pancreatitis	1.18e-05	3.53e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—pancreatitis	1.18e-05	3.52e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL8—pancreatitis	1.17e-05	3.49e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—HRAS—pancreatitis	1.16e-05	3.48e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HRAS—pancreatitis	1.16e-05	3.46e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARG—pancreatitis	1.16e-05	3.45e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—KRAS—pancreatitis	1.15e-05	3.44e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—INS—pancreatitis	1.13e-05	3.39e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CASP3—pancreatitis	1.12e-05	3.34e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—pancreatitis	1.11e-05	3.31e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALB—pancreatitis	1.1e-05	3.29e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HRAS—pancreatitis	1.06e-05	3.16e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARG—pancreatitis	1.05e-05	3.15e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALB—pancreatitis	1.04e-05	3.1e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—INS—pancreatitis	1.03e-05	3.09e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HRAS—pancreatitis	1.02e-05	3.06e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—pancreatitis	1.01e-05	3.03e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GCG—pancreatitis	9.93e-06	2.97e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—pancreatitis	9.81e-06	2.93e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—HRAS—pancreatitis	9.78e-06	2.92e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—pancreatitis	9.63e-06	2.88e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARG—pancreatitis	9.46e-06	2.83e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NRAS—pancreatitis	9.36e-06	2.8e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—pancreatitis	9.36e-06	2.8e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—INS—pancreatitis	9.28e-06	2.77e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARG—pancreatitis	9.23e-06	2.76e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—pancreatitis	9.1e-06	2.72e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—INS—pancreatitis	9.06e-06	2.7e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARG—pancreatitis	8.7e-06	2.6e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFB1—pancreatitis	8.7e-06	2.6e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARG—pancreatitis	8.63e-06	2.58e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—INS—pancreatitis	8.54e-06	2.55e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALB—pancreatitis	8.51e-06	2.54e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—INS—pancreatitis	8.46e-06	2.53e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALB—pancreatitis	8.3e-06	2.48e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—pancreatitis	8.29e-06	2.48e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—KRAS—pancreatitis	8.06e-06	2.41e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALB—pancreatitis	7.82e-06	2.34e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—LPL—pancreatitis	7.79e-06	2.33e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALB—pancreatitis	7.76e-06	2.32e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—pancreatitis	7.44e-06	2.22e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—pancreatitis	7.26e-06	2.17e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HRAS—pancreatitis	6.85e-06	2.05e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—pancreatitis	6.85e-06	2.04e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—pancreatitis	6.79e-06	2.03e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—pancreatitis	6.56e-06	1.96e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARG—pancreatitis	5.69e-06	1.7e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—INS—pancreatitis	5.58e-06	1.67e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALB—pancreatitis	5.12e-06	1.53e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—pancreatitis	4.48e-06	1.34e-05	CbGpPWpGaD
